DOI QR코드

DOI QR Code

Generation and analysis of whole-genome sequencing data in human mammary epithelial cells

  • Jong-Lyul Park (Personalized Genomic Medicine Research Center, KRIBB) ;
  • Jae-Yoon Kim (Personalized Genomic Medicine Research Center, KRIBB) ;
  • Seon-Young Kim (Personalized Genomic Medicine Research Center, KRIBB) ;
  • Yong Sun Lee (Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center)
  • 투고 : 2022.07.26
  • 심사 : 2022.12.23
  • 발행 : 2023.03.31

초록

Breast cancer is the most common cancer worldwide, and advanced breast cancer with metastases is incurable mainly with currently available therapies. Therefore, it is essential to understand molecular characteristics during the progression of breast carcinogenesis. Here, we report a dataset of whole genomes from the human mammary epithelial cell system derived from a reduction mammoplasty specimen. This system comprises pre-stasis 184D cells, considered normal, and seven cell lines along cancer progression series that are immortalized or additionally acquired anchorage-independent growth. Our analysis of the whole-genome sequencing (WGS) data indicates that those seven cancer progression series cells have somatic mutations whose number ranges from 8,393 to 39,564 (with an average of 30,591) compared to 184D cells. These WGS data and our mutation analysis will provide helpful information to identify driver mutations and elucidate molecular mechanisms for breast carcinogenesis.

키워드

과제정보

This work was supported by grants from: National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (NRF-2017M3A9B5060884 to J-LP and S-YK) and the National Cancer Center Korea (NCC-2110190 to YSL).

참고문헌

  1. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019;69:438-451. https://doi.org/10.3322/caac.21583
  2. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers 2019;5:66.
  3. Labarge MA, Garbe JC, Stampfer MR. Processing of human reduction mammoplasty and mastectomy tissues for cell culture. J Vis Exp 2013;(71):50011.
  4. Hines WC, Kuhn I, Thi K, Chu B, Stanford-Moore G, Sampayo R, et al. 184AA3: a xenograft model of ER+ breast adenocarcinoma. Breast Cancer Res Treat 2016;155:37-52. https://doi.org/10.1007/s10549-015-3649-z
  5. Lee JK, Garbe JC, Vrba L, Miyano M, Futscher BW, Stampfer MR, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol 2015;3:13.
  6. Garbe JC, Vrba L, Sputova K, Fuchs L, Novak P, Brothman AR, et al. Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. Cell Cycle 2014;13:3423-3435. https://doi.org/10.4161/15384101.2014.954456
  7. Stampfer MR, Garbe J, Nijjar T, Wigington D, Swisshelm K, Yaswen P. Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines. Oncogene 2003;22:5238-5251. https://doi.org/10.1038/sj.onc.1206667
  8. Stampfer MR, Bartley JC. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci U S A 1985;82:2394-2398. https://doi.org/10.1073/pnas.82.8.2394
  9. Garbe JC, Bhattacharya S, Merchant B, Bassett E, Swisshelm K, Feiler HS, et al. Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res 2009;69:7557-7568. https://doi.org/10.1158/0008-5472.CAN-09-0270
  10. Park JL, Lee YS, Song MJ, Hong SH, Ahn JH, Seo EH, et al. Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis. Oncogene 2017;36:6793-6804. https://doi.org/10.1038/onc.2017.285
  11. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589-595. https://doi.org/10.1093/bioinformatics/btp698
  12. Garcia-Alcalde F, Okonechnikov K, Carbonell J, Cruz LM, Gotz S, Tarazona S, et al. Qualimap: evaluating next-generation sequencing alignment data. Bioinformatics 2012;28:2678-2679. https://doi.org/10.1093/bioinformatics/bts503
  13. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-1303. https://doi.org/10.1101/gr.107524.110
  14. Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, Kallberg M, et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods 2018;15:591-594. https://doi.org/10.1038/s41592-018-0051-x
  15. Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 2018;28:1747-1756. https://doi.org/10.1101/gr.239244.118
  16. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010;38:576-589. https://doi.org/10.1016/j.molcel.2010.05.004
  17. Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Tamborero D, Schroeder MP, Jene-Sanz A, et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat Methods 2013;10:1081-1082. https://doi.org/10.1038/nmeth.2642
  18. Alioto TS, Buchhalter I, Derdak S, Hutter B, Eldridge MD, Hovig E, et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nat Commun 2015;6:10001.
  19. Severson PL, Vrba L, Stampfer MR, Futscher BW. Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen 2014;775-776:48-54. https://doi.org/10.1016/j.mrgentox.2014.10.011
  20. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol 2015;26:1291-1299. https://doi.org/10.1093/annonc/mdv022